JP2012176975A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012176975A5 JP2012176975A5 JP2012127232A JP2012127232A JP2012176975A5 JP 2012176975 A5 JP2012176975 A5 JP 2012176975A5 JP 2012127232 A JP2012127232 A JP 2012127232A JP 2012127232 A JP2012127232 A JP 2012127232A JP 2012176975 A5 JP2012176975 A5 JP 2012176975A5
- Authority
- JP
- Japan
- Prior art keywords
- tiotropium bromide
- crystal
- crystals
- pharmaceutical formulation
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 claims 15
- 229960000257 tiotropium bromide Drugs 0.000 claims 15
- 239000013078 crystal Substances 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 238000004519 manufacturing process Methods 0.000 claims 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims 4
- 238000001757 thermogravimetry curve Methods 0.000 claims 2
- MQLXPRBEAHBZTK-SEINRUQRSA-M tiotropium bromide hydrate Chemical compound O.[Br-].C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 MQLXPRBEAHBZTK-SEINRUQRSA-M 0.000 claims 2
- 238000000113 differential scanning calorimetry Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 238000000634 powder X-ray diffraction Methods 0.000 claims 1
- 239000012453 solvate Substances 0.000 claims 1
- 238000002411 thermogravimetry Methods 0.000 claims 1
- 230000004580 weight loss Effects 0.000 claims 1
Applications Claiming Priority (16)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75267205P | 2005-12-19 | 2005-12-19 | |
| US60/752,672 | 2005-12-19 | ||
| US75453005P | 2005-12-27 | 2005-12-27 | |
| US60/754,530 | 2005-12-27 | ||
| US76143706P | 2006-01-23 | 2006-01-23 | |
| US60/761,437 | 2006-01-23 | ||
| US77405106P | 2006-02-15 | 2006-02-15 | |
| US60/774,051 | 2006-02-15 | ||
| US78031006P | 2006-03-07 | 2006-03-07 | |
| US60/780,310 | 2006-03-07 | ||
| US83218906P | 2006-07-20 | 2006-07-20 | |
| US60/832,189 | 2006-07-20 | ||
| US85122306P | 2006-10-12 | 2006-10-12 | |
| US60/851,223 | 2006-10-12 | ||
| US85274006P | 2006-10-18 | 2006-10-18 | |
| US60/852,740 | 2006-10-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538130A Division JP5086267B2 (ja) | 2005-12-19 | 2006-12-19 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012176975A JP2012176975A (ja) | 2012-09-13 |
| JP2012176975A5 true JP2012176975A5 (enExample) | 2012-10-25 |
Family
ID=38115166
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538130A Active JP5086267B2 (ja) | 2005-12-19 | 2006-12-19 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
| JP2012037796A Active JP5567610B2 (ja) | 2005-12-19 | 2012-02-23 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
| JP2012127232A Pending JP2012176975A (ja) | 2005-12-19 | 2012-06-04 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008538130A Active JP5086267B2 (ja) | 2005-12-19 | 2006-12-19 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
| JP2012037796A Active JP5567610B2 (ja) | 2005-12-19 | 2012-02-23 | 臭化チオトロピウムの新規な形態およびそれを製造する方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (4) | US8163913B2 (enExample) |
| EP (2) | EP2123650B1 (enExample) |
| JP (3) | JP5086267B2 (enExample) |
| KR (1) | KR101395881B1 (enExample) |
| CN (1) | CN102731494A (enExample) |
| AT (1) | ATE552256T1 (enExample) |
| BR (1) | BRPI0608427A2 (enExample) |
| CA (1) | CA2627729A1 (enExample) |
| DK (1) | DK1869035T4 (enExample) |
| ES (2) | ES2396978T5 (enExample) |
| IL (1) | IL187947A0 (enExample) |
| MX (1) | MX2007009988A (enExample) |
| PL (2) | PL2123650T3 (enExample) |
| PT (1) | PT1869035E (enExample) |
| RS (1) | RS52663B2 (enExample) |
| TW (1) | TW200732340A (enExample) |
| WO (1) | WO2007075858A2 (enExample) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9108962B2 (en) * | 2005-12-19 | 2015-08-18 | Sicor, Inc. | Forms of tiotropium bromide and processes for preparation thereof |
| KR101395881B1 (ko) * | 2005-12-19 | 2014-05-21 | 시코르, 인크. | 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법 |
| GB0716026D0 (en) | 2007-08-16 | 2007-09-26 | Norton Healthcare Ltd | An inhalable medicament |
| HRP20141004T1 (hr) * | 2008-01-10 | 2015-02-13 | Generics | Novi postupak pripreme estera skopina |
| EP2172190A1 (en) * | 2008-10-02 | 2010-04-07 | Laboratorios Liconsa, S.A. | Inhalable particles comprising tiotropium |
| KR101557633B1 (ko) * | 2008-11-04 | 2015-10-06 | 시플라 리미티드 | 낮은 결정화도를 갖는 티오트로피움 브로마이드 |
| EP2362766A2 (en) * | 2008-11-04 | 2011-09-07 | Cipla Limited | Pharmaceutical aerosol composition |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
| CA2931876A1 (en) * | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
| TR201111589A2 (tr) * | 2011-03-03 | 2012-09-21 | Bi̇lgi̇ç Mahmut | Tiotropyum bromür susuz kristal formu. |
| CZ304368B6 (cs) | 2011-11-28 | 2014-04-02 | Zentiva, K.S. | Směsný solvát tiotropium bromidu a způsob jeho přípravy |
| GB201200525D0 (en) | 2011-12-19 | 2012-02-29 | Teva Branded Pharmaceutical Prod R & D Inc | An inhalable medicament |
| PT106142B (pt) * | 2012-02-10 | 2014-07-18 | Hovione Farmaci Ncia S A | Processo para a preparação de brometo de tiotrópio |
| EP2705838A1 (en) * | 2012-09-06 | 2014-03-12 | Xspray Microparticles Ab | Tiotropium preparations |
| WO2014042605A1 (en) * | 2012-09-11 | 2014-03-20 | Mahmut Bilgic | New tiotropium bromide crystalline form |
| ME02679B (me) | 2012-11-05 | 2017-06-20 | Zentiva Ks | Stabilizacija tiotropij solvata |
| CA2907566C (en) | 2013-04-01 | 2023-08-22 | Pulmatrix, Inc. | Tiotropium dry powders |
| EP2789611A1 (en) * | 2013-04-08 | 2014-10-15 | Cerbios-Pharma S.A. | A crystalline form of tiotropium bromide |
| US10034866B2 (en) | 2014-06-19 | 2018-07-31 | Teva Branded Pharmaceutical Products R&D, Inc. | Inhalable medicament comprising tiotropium |
| RU2567539C1 (ru) * | 2015-02-04 | 2015-11-10 | Индивидуальный предприниматель Михайлов Олег Ростиславович | КРИСТАЛЛИЧЕСКАЯ γ-МОДИФИКАЦИЯ (1α,2β,4β,5α,7β-7)-[(ГИДРОКСИДИ-2-ТИЕНИЛАЦЕТИЛ)ОКСИ]-9,9-ДИМЕТИЛ-3-ОКСА-9-АЗОНИАТРИЦИКЛО[3.3.1.02,4]НОНАН БРОМИДА МОНОГИДРАТА, СПОСОБ ЕЁ ПОЛУЧЕНИЯ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕЁ ОСНОВЕ |
| WO2017138896A1 (en) | 2016-02-11 | 2017-08-17 | Sima Patent Ve Lisanslama Hizmetleri Ltd. Şti | Crystalline form of tiotropium bromide anhydrate |
| WO2020013330A1 (ja) * | 2018-07-13 | 2020-01-16 | 協和発酵バイオ株式会社 | ユーコミン酸の非溶媒和物結晶及びその製造方法 |
| PT115583B (pt) | 2019-06-17 | 2022-05-02 | Hovione Farm S A | Processo contínuo para a preparação de medicamentos anticolinérgicos |
| EP4108230A1 (en) | 2021-06-24 | 2022-12-28 | Laboratoires SMB | New dry powder composition of tiotropium for inhalation |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3931041C2 (de) | 1989-09-16 | 2000-04-06 | Boehringer Ingelheim Kg | Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel |
| US5610163A (en) | 1989-09-16 | 1997-03-11 | Boehringer Ingelheim Gmbh | Esters of thienyl carboxylic acids and amino alcohols and their quaternization products |
| US6736830B2 (en) | 2000-08-22 | 2004-05-18 | Deborah M. Roust | Baby pacifier |
| US6908928B2 (en) | 2000-10-12 | 2005-06-21 | Bi Pharma Kg. | Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions |
| PL200063B1 (pl) * | 2000-10-12 | 2008-12-31 | Boehringer Ingelheim Pharma | Nowe proszki do inhalacji zawierające tiotropium |
| DE50103666D1 (de) * | 2000-10-12 | 2004-10-21 | Boehringer Ingelheim Pharma | Kristallines monohydrat von tiotropiumbromid, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels |
| DE10064816A1 (de) * | 2000-12-22 | 2002-06-27 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung eines Anticholinergikums |
| PL208137B1 (pl) * | 2001-06-22 | 2011-03-31 | Boehringer Ingelheim Pharma | Bezwodny krystaliczny bromek tiotropium, sposób jego wytwarzania i zastosowanie krystalicznego monohydratu bromku tiotropium do wytwarzania krystalicznego bezwodnego bromku tiotropium |
| US6608055B2 (en) | 2001-06-22 | 2003-08-19 | Boehringer Ingelheim Pharma Kg | Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition |
| US6890291B2 (en) | 2001-06-25 | 2005-05-10 | Mission Medical, Inc. | Integrated automatic blood collection and processing unit |
| US6627646B2 (en) * | 2001-07-17 | 2003-09-30 | Sepracor Inc. | Norastemizole polymorphs |
| DE10212264A1 (de) * | 2002-03-20 | 2003-10-02 | Boehringer Ingelheim Pharma | Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels |
| EP1575588A1 (en) * | 2002-12-16 | 2005-09-21 | Boehringer Ingelheim Pharma GmbH & Co.KG | Tiotropium containing hfc solution formulations |
| UA83813C2 (ru) * | 2002-12-20 | 2008-08-26 | Бёрингер Ингельхайм Фарма Гмбх & Ко. Кг | Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола |
| DE10351196B4 (de) | 2003-10-28 | 2016-08-04 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Verwendung einer anodisch mit Silizium bondbaren Glas-Keramik (LTCC) |
| UY28590A1 (es) * | 2003-11-03 | 2005-06-30 | Boehringer Ingelheim Int | Procedimiento para la preparación de nuevas sales de tiotropio, nuevas sales de tiotropio como tales, así como las formulaciones medicamentosas que las contienen. |
| CN100509809C (zh) | 2003-11-03 | 2009-07-08 | 贝林格尔·英格海姆国际有限公司 | 具有抗胆碱能作用的新颖无水晶体 |
| EP2083007B1 (de) * | 2003-11-03 | 2013-04-24 | Boehringer Ingelheim International Gmbh | Tiotropiumsalze, Verfahren zu deren Herstellung sowie diese enthaltende Arzneimittelformulierungen |
| US7968717B2 (en) * | 2003-11-03 | 2011-06-28 | Boehringer Ingelhein International Gmbh | Crystalline anhydrate with anticholinergic efficacy |
| CN1271073C (zh) | 2004-10-26 | 2006-08-23 | 江苏正大天晴药业股份有限公司 | 结晶性抗胆碱能药噻托溴铵晶体 |
| EP1879888A2 (en) * | 2005-05-02 | 2008-01-23 | Boehringer Ingelheim International GmbH | Crystalline forms of tiotropium bromide |
| JP5227790B2 (ja) | 2005-05-02 | 2013-07-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 新規結晶性臭化チオトロピウム |
| KR101395881B1 (ko) * | 2005-12-19 | 2014-05-21 | 시코르, 인크. | 브롬화 티오트로피움의 신규한 형태 및 이의 제조 방법 |
| SI1869035T2 (sl) * | 2005-12-19 | 2015-12-31 | Sicor, Inc. | Nove kristalne oblike tiotropij bromida in postopek njihove priprave |
| EP1923393A1 (en) | 2006-11-17 | 2008-05-21 | Boehringer Ingelheim Pharma GmbH & Co. KG | Crystalline form of tiotropium bromide and urea |
| EP2020403A1 (en) * | 2007-08-02 | 2009-02-04 | Esteve Quimica, S.A. | Process for the resolution of zopiclone and intermediate compounds |
| CA2931876A1 (en) * | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Anhydrate of tiotropium bromide |
| WO2011015883A1 (en) | 2009-08-07 | 2011-02-10 | Generics [Uk] Limited | Dichloromethane solvate of tiotropium bromide and its use |
-
2006
- 2006-12-19 KR KR1020077018777A patent/KR101395881B1/ko active Active
- 2006-12-19 CA CA002627729A patent/CA2627729A1/en not_active Abandoned
- 2006-12-19 CN CN201210232788XA patent/CN102731494A/zh active Pending
- 2006-12-19 PL PL09010563T patent/PL2123650T3/pl unknown
- 2006-12-19 JP JP2008538130A patent/JP5086267B2/ja active Active
- 2006-12-19 US US11/643,001 patent/US8163913B2/en active Active
- 2006-12-19 WO PCT/US2006/048734 patent/WO2007075858A2/en not_active Ceased
- 2006-12-19 TW TW095147754A patent/TW200732340A/zh unknown
- 2006-12-19 ES ES06847887.4T patent/ES2396978T5/es active Active
- 2006-12-19 PL PL06847887T patent/PL1869035T5/pl unknown
- 2006-12-19 BR BRPI0608427-3A patent/BRPI0608427A2/pt not_active IP Right Cessation
- 2006-12-19 PT PT68478874T patent/PT1869035E/pt unknown
- 2006-12-19 EP EP09010563A patent/EP2123650B1/en active Active
- 2006-12-19 DK DK06847887.4T patent/DK1869035T4/en active
- 2006-12-19 ES ES09010563T patent/ES2384486T3/es active Active
- 2006-12-19 RS RS20120583A patent/RS52663B2/sr unknown
- 2006-12-19 AT AT09010563T patent/ATE552256T1/de active
- 2006-12-19 MX MX2007009988A patent/MX2007009988A/es unknown
- 2006-12-19 EP EP06847887.4A patent/EP1869035B2/en active Active
-
2007
- 2007-12-06 IL IL187947A patent/IL187947A0/en unknown
-
2011
- 2011-12-28 US US13/339,042 patent/US8846926B2/en active Active
-
2012
- 2012-02-23 JP JP2012037796A patent/JP5567610B2/ja active Active
- 2012-03-05 US US13/412,586 patent/US20120165364A1/en not_active Abandoned
- 2012-06-04 JP JP2012127232A patent/JP2012176975A/ja active Pending
-
2013
- 2013-10-31 US US14/068,998 patent/US20140057935A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI3102208T4 (fi) | 2-hydroksi-6-((2-(1-isopropyyli-1h-pyratsol-5-yyli)pyridin-3-yyli)metoksi)bentsaldehydin vapaan emäksen kiteinen polymorfi | |
| JP2013237682A5 (enExample) | ||
| JP2014525470A5 (enExample) | ||
| JP2013543867A5 (enExample) | ||
| JP2015500331A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| PH12014502363A1 (en) | N-aryltriazole compounds as lpar antagonists | |
| NZ741907A (en) | 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof | |
| ES2613716T3 (es) | Formas cristalinas de un derivado de purina | |
| JP2015044837A5 (enExample) | ||
| JP2012531408A5 (enExample) | ||
| UA129695C2 (uk) | Спосіб отримання та кристалічні форми проміжного продукту в синтезі інгібітора mdm2 | |
| IL217052A0 (en) | Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them | |
| MX2013005833A (es) | Nuevos compuestos de piridina fusionada como inhibidores de caseina quinasa. | |
| JP2014507477A5 (enExample) | ||
| JP2015522037A5 (enExample) | ||
| WO2013188283A8 (en) | Topical ophthalmological pharmaceutical composition containing sunitinib | |
| JP2016510768A5 (enExample) | ||
| NZ605827A (en) | Co-crystals and salts of ccr3-inhibitors | |
| JP2014513712A5 (enExample) | ||
| RU2016100972A (ru) | Стабильная кристаллическая форма типирацила гидрохлорида и способ ее кристаллизации | |
| JP2015516425A5 (enExample) | ||
| WO2013140265A3 (en) | Fertility enhancing agent | |
| HRP20150356T1 (hr) | Kristalni oblici soli prasugrela | |
| JP2016510767A5 (enExample) |